Skip to content

Expert Answer · Dietary Supplements

What are the most common 21 CFR Part 111 quality-system weaknesses?

Incoming component identity testing that is skipped or delegated to a supplier certificate without qualification, master manufacturing records that do not match what production runs, and finished-batch release decisions made without complete specification testing.

Component identity is the recurring one

Part 111 requires at least one appropriate test or examination to verify the identity of a dietary ingredient before use. Relying on a supplier's certificate of analysis is only defensible with a documented qualification of that supplier and a rationale for the exemption — and that file is frequently missing.

Master and batch records that have drifted

  • Master manufacturing records that do not reflect current equipment or sequence
  • Batch records missing the in-process controls the MMR requires
  • Theoretical versus actual yield reconciliation performed inconsistently
  • Deviations recorded on the floor but not routed into an investigation

Release without complete data

Product released on the basis of partial testing, or on a specification that was never justified, is a quality unit problem rather than a laboratory problem. Specifications should be traceable to a documented rationale — label claim, safety limit, or a validated process capability.

Where remediation should start

Fix the specification set and the component qualification file first. Almost every other Part 111 finding is downstream of those two, and correcting them makes the rest of the remediation smaller.

Reviewed by the named consultant. Last updated July 14, 2026. General information only — not regulatory or legal advice for a specific situation.

Start a project

Tell us what you're working on.

Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.

CallStart a Project